Cargando…

Performance Characteristics of BinaxNOW COVID-19 Antigen Card for Screening Asymptomatic Individuals in a University Setting

We compared the performance of the Abbott BinaxNOW COVID-19 antigen card to that of a standard reverse transcription-PCR (RT-PCR) assay (Thermo Fisher TaqPath COVID-19 Combo kit) for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 2,645 asymptomatic students presenti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okoye, Nkemakonam C., Barker, Adam P., Curtis, Kenneth, Orlandi, Richard R., Snavely, Emily A., Wright, Cameron, Hanson, Kimberly E., Pearson, Lauren N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Virology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092740/ https://www.ncbi.nlm.nih.gov/pubmed/33509809 http://dx.doi.org/10.1128/JCM.03282-20

Ejemplares similares

Analytical Sensitivity of the Abbott BinaxNOW COVID-19 Ag Card
por: Perchetti, Garrett A., et al.
Publicado: (2021)

Accuracy of Expired BinaxNOW Rapid Antigen Tests
por: Vaeth, Mary Jane E., et al.
Publicado: (2023)

Diagnostic value of BinaxNOW antigen card for Severe Acute Respiratory Syndrome Coronavirus 2
por: Mai, Yue-Xue, et al.
Publicado: (2023)

Performance Characteristics of the Abbott BinaxNOW SARS-CoV-2 Antigen Test in Comparison to Real-Time Reverse Transcriptase PCR and Viral Culture in Community Testing Sites during November 2020
por: Almendares, Olivia, et al.
Publicado: (2022)

The BinaxNOW pneumococcal antigen test: An adjunct for diagnosis of pneumococcal bacteraemia
por: Tootla, Hafsah D., et al.
Publicado: (2021)

Comparison of Sofia Legionella FIA and BinaxNOW® Legionella urinary antigen card in two national reference centers
por: Beraud, L., et al.
Publicado: (2015)

Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening
por: Stokes, Nadarra L., et al.
Publicado: (2021)

Comparison of a Prototype SARS-CoV-2 Lateral Flow IMMUNOASSAY with the BinaxNOW(TM) COVID-19 Antigen CARD
por: Hill, Haydon J., et al.
Publicado: (2022)

Comparison of the ImmuView and the BinaxNOW antigen tests in detection of Streptococcus pneumoniae and Legionella pneumophila in urine
por: Athlin, S., et al.
Publicado: (2017)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

Detection of the Omicron Variant Virus With the Abbott BinaxNow SARS-CoV-2 Rapid Antigen Assay
por: Regan, James, et al.
Publicado: (2022)

Implementation and Accuracy of BinaxNOW Rapid Antigen COVID-19 Test in Asymptomatic and Symptomatic Populations in a High-Volume Self-Referred Testing Site
por: Siddiqui, Zishan K., et al.
Publicado: (2021)

Effectiveness of Abbott BinaxNOW Rapid Antigen Test for Detection of SARS-CoV-2 Infections in Outbreak among Horse Racetrack Workers, California, USA
por: Surasi, Krishna, et al.
Publicado: (2021)

Performance of BinaxNOW G6PD Deficiency Point-of-Care Diagnostic in P. vivax-Infected Subjects
por: Osorio, Lyda, et al.
Publicado: (2015)

366. Abbott BinaxNOW Rapid Antigen Test Performance in Detecting SARS-CoV-2 Infections in a COVID-19 Outbreak Among Horse Racetrack Workers
por: Surasi, Krishna, et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW rapid antigen test for SARS-CoV-2 infection in children: Implications for screening in a school setting
por: Sood, Neeraj, et al.
Publicado: (2021)

High Sensitivity and NPV for BinaxNOW Rapid Antigen Test in Children at a Mass Testing Site during Prevalent Delta Variant Period
por: Sun, Kristie J., et al.
Publicado: (2022)

Multidisciplinary assessment of the Abbott BinaxNOW SARS-CoV-2 point-of-care antigen test in the context of emerging viral variants and self-administration
por: Frediani, Jennifer K., et al.
Publicado: (2021)

Evaluation of the Abbott BinaxNOW COVID-19 Test Ag Card for rapid detection of SARS-CoV-2 infection by a local public health district with a rural population
por: Pollreis, Rachel E., et al.
Publicado: (2021)

SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 antigen self tests
por: Nguyen, Phuong-Vi, et al.
Publicado: (2023)

Field assessment of BinaxNOW antigen tests as COVID-19 treatment entry point at a community testing site in San Francisco during evolving omicron surges
por: Schrom, John, et al.
Publicado: (2023)

Comparison of BinaxNOW and SARS-CoV-2 qRT-PCR Detection of the Omicron Variant from Matched Anterior Nares Swabs
por: Landaverde, Lena, et al.
Publicado: (2022)

Performance of the ImmuView and BinaxNOW assays for the detection of urine and cerebrospinal fluid Streptococcus pneumoniae and Legionella pneumophila serogroup 1 antigen in patients with Legionnaires’ disease or pneumococcal pneumonia and meningitis
por: Edelstein, Paul H., et al.
Publicado: (2020)

Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020
por: Prince-Guerra, Jessica L., et al.
Publicado: (2021)

Performance of the BinaxNOW coronavirus disease 2019 (COVID-19) Antigen Card test relative to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) real-time reverse transcriptase polymerase chain reaction (rRT-PCR) assay among symptomatic and asymptomatic healthcare employees
por: James, Allison E., et al.
Publicado: (2021)

Diagnostic utility of BINAX NOW RSV – an evaluation of the diagnostic performance of BINAX NOW RSV in comparison with cell culture and direct immunofluorescence
por: Jonathan, Nteimam
Publicado: (2006)

Limitations of Molecular and Antigen Test Performance for SARS-CoV-2 in Symptomatic and Asymptomatic COVID-19 Contacts
por: Robinson, Matthew L., et al.
Publicado: (2022)

Self-Collected Anterior Nasal and Saliva Specimens versus Health Care Worker-Collected Nasopharyngeal Swabs for the Molecular Detection of SARS-CoV-2
por: Hanson, K. E., et al.
Publicado: (2020)

Field Performance and Public Health Response Using the BinaxNOW(TM) Rapid Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen Detection Assay During Community-Based Testing
por: Pilarowski, Genay, et al.
Publicado: (2020)

Diagnostic Accuracy of SARS-CoV-2 Rapid Antigen Detection Testing in Symptomatic and Asymptomatic Children in the Clinical Setting
por: L’Huillier, Arnaud G., et al.
Publicado: (2021)

Establishing conditions for the storage and elution of rabies virus RNA using FTA(®) cards
por: SAKAI, Takeo, et al.
Publicado: (2014)

Multicenter Postimplementation Assessment of the Positive Predictive Value of SARS-CoV-2 Antigen-Based Point-of-Care Tests Used for Screening of Asymptomatic Continuing Care Staff
por: Kanji, Jamil N., et al.
Publicado: (2021)

Comparison of an ID NOW COVID-19 Assay Used at the Point of Care to Laboratory-Based Nucleic Acid Amplification Tests
por: Payne, David, et al.
Publicado: (2023)

Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution
por: Basu, Atreyee, et al.
Publicado: (2020)

Separation of Plasma from Whole Blood by Use of the cobas Plasma Separation Card: a Compelling Alternative to Dried Blood Spots for Quantification of HIV-1 Viral Load
por: Carmona, Sergio, et al.
Publicado: (2019)

Characterization of the Cytopathic Effects of Monkeypox Virus Isolated from Clinical Specimens and Differentiation from Common Viral Exanthems
por: Ma, Angela, et al.
Publicado: (2022)

Comparison of Upper Respiratory Viral Load Distributions in Asymptomatic and Symptomatic Children Diagnosed with SARS-CoV-2 Infection in Pediatric Hospital Testing Programs
por: Kociolek, Larry K., et al.
Publicado: (2020)

Assessment of sample pooling for SARS-CoV-2 molecular testing for screening of asymptomatic persons in Tunisia
por: Abid, Salma, et al.
Publicado: (2020)

Comparative study of four SARS-CoV-2 Nucleic Acid Amplification Test (NAAT) platforms demonstrates that ID NOW performance is impaired substantially by patient and specimen type()
por: Lephart, Paul R., et al.
Publicado: (2021)

How many are we missing with ID NOW COVID-19 assay using direct nasopharyngeal swabs? Findings from a mid-sized academic hospital clinical microbiology laboratory
por: Thwe, Phyu M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dg3q3bo8d6clrmnnmqiaqur2aj